Market

Inside Mabion’s Transformation Gregor Kawaletz on Scaling, Strategy & Biologic CDMO Ambitions

Executing Mabion’s CDMO Vision: Insights from CEO Gregor Kawaletz

International Day of Women and Girls in Science 2026. Mabion support women in pharma.

How Mabion Builds Space for Women in Biopharma

Biologics CDMO Excellence Awards Europe 2025 Tech Transfer Team of the Year for Mabion Biologics CDMO

Mabion’s Tech Transfer Team wins Biologics CDMO Excellence Europe 2025

Life Science Marketing, Life Science Sales and Marketing Awards

Mabion named finalist in four categories at the Life Science Sales & Marketing Awards 2025

Jakub Knurek, a marketing specialist at Mabion with a strong foundation in the sciences, has been announced as a finalist for the Future Leader category at the CPHI Pharma Awards 2025, set to take place during CPHI Frankfurt on 28 October.

Jakub Knurek became a finalist of the CPHI Pharma Awards in the Future Leader category

Biologics CDMO is calling. Read more about the biopharma market outlook from Marty and Nigel.

Biologics CDMO Market – Mabion Approach to Establishing Cooperation

Mabion - 2025 CDMO Leadership Awards Champion in International Biologics

Winning Trust Through Mabion Biologics CDMO Excellence – exclusive interview with Marty Henehan

The use of GLP-1 analogs is growing rapidly in obese and overweight patients who need to control body weight.

Huge spike in the use of GLP-1 analogs amid severe shortages